tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Collegium Pharmaceutical Reports Record Q2 2025 Revenue
PremiumCompany AnnouncementsCollegium Pharmaceutical Reports Record Q2 2025 Revenue
1M ago
Collegium Pharmaceutical reports Q2 adjusted EPS $1.68, consensus $1.85
Premium
The Fly
Collegium Pharmaceutical reports Q2 adjusted EPS $1.68, consensus $1.85
1M ago
Collegium raises FY25 revenue view to $745M-$760M from $735M-$750M
Premium
The Fly
Collegium raises FY25 revenue view to $745M-$760M from $735M-$750M
1M ago
Collegium Pharmaceutical’s Earnings Call Highlights Growth and Strategic Initiatives
PremiumCompany AnnouncementsCollegium Pharmaceutical’s Earnings Call Highlights Growth and Strategic Initiatives
4M ago
Collegium Pharmaceutical price target raised to $37 from $36 at Piper Sandler
Premium
The Fly
Collegium Pharmaceutical price target raised to $37 from $36 at Piper Sandler
4M ago
Strong Buy Rating for Collegium Pharmaceutical Driven by Robust 2025 Performance and Growth Potential
Premium
Ratings
Strong Buy Rating for Collegium Pharmaceutical Driven by Robust 2025 Performance and Growth Potential
4M ago
Is COLL a Buy, Before Earnings?
PremiumPre-EarningsIs COLL a Buy, Before Earnings?
4M ago
Buy Recommendation for Collegium Pharmaceutical Driven by Stability and Growth Potential
Premium
Ratings
Buy Recommendation for Collegium Pharmaceutical Driven by Stability and Growth Potential
5M ago
Collegium Pharmaceutical: Undervalued Stock with Strong Growth Potential and Low Risk
Premium
Ratings
Collegium Pharmaceutical: Undervalued Stock with Strong Growth Potential and Low Risk
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100